On the bacteriocin plasmid p9B4-6 of Lactococcus lactis subsp. cremoris 9B4, a third bacteriocin determinant was identified. The genes encoding bacteriocin production and immunity resided on a 1.2-kb Celll-ScaI fragment and were located adjacent to one of two previously identified bacteriocin operons (M. J. van Belkum, B. J. Hayema, R. E. Jeeninga, J. Kok, and G. Venema, Appl. Environ. Microbiol. 57:492-498, 1991). The fragment was sequenced and analyzed by deletion and mutation analyses. The bacteriocin determinant consisted of two genes which were transcribed as an operon. The first gene (lcnB), containing 68 codons, was involved in bacteriocin activity. The second gene (lciB) contained 91 codons and was responsible for immunity. The specificity of this novel bacteriocin, designated lactococcin B, was different from that of the other two bacteriocins specified by p9B4-6. Part of the nucleotide sequence of the lactococcin B operon was similar to a nucleotide sequence also found in the two other bacteriocin operons of p9B4-6. This conserved region encompassed a nucleotide sequence upstream of the bacteriocin gene and the 5' part of the gene. When the lactococcin B operon was expressed in Escherichia coli by using a T7 RNA polymerase-specific promoter, antagonistic activity could be detected.
Lactic acid bacteria produce a variety of substances with antimicrobial activity which are of potential interest for food fermentation and preservation. In many cases, it has been shown that the compounds responsible for antagonistic activity, termed bacteriocins, were of a proteinaceous nature (16) . Although numerous reports on the detection and biochemical characterization of bacteriocins produced by lactic acid bacteria are available, knowledge concerning their genetics is scarce. The genetic determinants for bacteriocin activity were shown to be plasmid encoded in several species (7, 8, 15, 22, 24, 25, 29) , whereas other members of the lactic acid bacteria carried the bacteriocin genes on their chromosomes (1, 9, 13, 34) . A number of bacteriocin determinants have recently been cloned. Scherwitz-Harmon and McKay (29) located the bacteriocin determinants of Lactococcus lactis subsp. lactis WM4 on two BclI fragments from the 88-MDa plasmid pNP2. The structural genes of helveticin J from Lactobacillus helveticus 481 and lactacin F from Lactobacillus acidophilus 11088 have been cloned and sequenced (14, 24) . Additionally, the structural gene for prenisin has been cloned and sequenced from a number of lactococcal strains (4, 9, 15) .
The genetic determinants for bacteriocin production and immunity in L. lactis subsp. cremoris 9B4 are located on the 60-kb conjugative plasmid p9B4-6 (25) . From this plasmid, two fragments were cloned, each of which specified bacteriocin activity as well as immunity (35) . A 1.8-kb ScaI-ClaI fragment (contained in pMB225) specified low antagonistic activity, whereas the other, a 1.3-kb ScaI-HindIII fragment (present in pMB553), encoded high antagonistic activity. Sequence and mutation analyses (36) showed that the 1.8-kb fragment contained three open reading frames (ORFs); the first two (ORF-A1 and -A2) were involved in bacteriocin production, whereas the third (ORF-A3) was involved in * Corresponding author.
immunity. On the insert in pMB553, two ORFs were identified; the first one (ORF-B1) was responsible for bacteriocin activity, and the second (ORF-B2) specified immunity. Fig. 2 ), together with a 17-mer primer (5'-TTCAAAGTCTACCCTGA-3') complementary to a sequence in the noncoding strand upstream of the multiple cloning site of pMB580, were used for DNA amplification with pMB580 as template.
Bacteriocin assay. Screening of L. lactis transformants for bacteriocin activity has been described previously (35 (pMB553), but IL1403(pMB553) did not inhibit the growth of IL1403(pMB570). When IL1403 was used as the indicator strain, the size of the halo produced by IL1403(pMB570) was comparable to that produced by IL1403(pMB553) but somewhat reduced compared with that produced by IL1403 containing pMB500 (results not shown). When the 2.1-kb Scal fragment was deleted from pMB500, resulting in plasmid pMB510 (Fig. 1) , no antagonistic activity by L. lactis could be detected. The 2.1-kb Scal fragment contains a unique CelII site which was used to delete a 0.9-kb ScalCelII fragment carrying the lactococcin A operon. L. lactis IL1403 carrying the resulting plasmid, pMB580 (Fig. 1) , inhibited the growth of IL1403(pMB225) and IL1403 (pMB553) but was sensitive to the pMB225-and pMB553-specified bacteriocins. Apparently, we had succeeded in cloning a novel bacteriocin determinant that specified lactococcin B with a specificity different from that of the other two bacteriocins of p9B4-6.
Nucleotide sequence of the lactococcin B operon. The nucleotide sequence of the lactococcin B determinant present on the 2.1-kb Scal fragment is shown in Fig. 2 ORFs were preceded by a putative ribosome-binding site. An inverted repeat found 34 bp downstream of the TAA stop codon of the second ORF could act as a rho-independent terminator. The potential stem-and-loop structure had a AG of -82 kJ/mol. A stretch of 123 bp immediately upstream of the first ORF appeared to be almost identical to the nucleotide sequences upstream of the two other bacteriocin determinants of p9B4-6 (36), and therefore, the promoter sequences of the three bacteriocin operons are most probably identical (Fig. 2) . Furthermore, the 5' nucleotide sequence of the first ORF was identical to the first 20 bp of lcnM and almost identical to the first 64 bp of IcnA. No further nucleotide sequence similarity between the three bacteriocin operons could be found. The amino acid sequences deduced from both ORFs were compared with the deduced amino acid sequences from the genes of the two previously identified bacteriocin determinants of p9B4-6. Significant homology was found only between the N-terminal 21 amino acids of the polypeptides specified by the first ORF, 1cnA, and lcnM (Fig. 3) .
The lactococcin B operon contains genes for bacteriocin production and immunity. Both ORFs on the insert in pMB580 were subjected to in vitro deletion and mutagenesis.
The mutated plasmid derivatives were isolated from E. coli MH1 and transferred to L. lactis IL1403, and the transformants were screened for bacteriocin production and immunity. Figure 4 shows the properties of the various pMB580 derivatives. Filling in the Avall site with Klenow DNA polymerase resulted in the addition of an extra amino acid residue (Arg) between Gly-30 and Pro-31 in the first ORF (yielding plasmid pMB583). L. lactis cells containing this plasmid showed a Bac-Imm+ phenotype, which indicates that the first ORF, designated lcnB, is involved in bacteriocin production. Removal of the promoter region and the 5' part of IcnB by deleting the 0.31-kb CelII-HindIII fragment of pMB580 (pMB582) resulted in loss of bacteriocin activity as well as immunity, suggesting that the second ORF is involved in immunity and is transcribed from the same promoter as IcnB. Transformation of L. lactis with pMB581, which carries a frameshift mutation in the presumed immunity gene, by filling in the BstNI site of the second ORF gave rise to very small colonies of bacteriocin-producing transformants. When the growth medium was supplemented with 30% (vol/vol) supernatant of the bacteriocin-producing strain IL1403(pMB580), no transformants could be detected on the plates. Apparently, as was observed before (36), the initial concentration of bacteriocin produced by L. lactis transformants carrying a nonfunctional immunity gene was too low to completely inhibit the growth of the transformants. These results imply that the second ORF, designated IciB, indeed encodes immunity. 
GTATAAAGATACTAGAACAGGAAAKACAATAIGTAAACAGACAATIGACACAGCAAGTTATACATTFGGVGTAAMGGCAGAAGGA;GGG Y K D T R T G K T I C K Q T I D T A S Y T F G V t A E G W G
stop lcnB rbs start lciB AAAAACATTCCACTAATAAAAAAAACTGGTTTGAGTTAATGAAAAAAAATTGATACAAAAAACAAATTACIACTTGGGCATCT Lactococcin B production in E. coli. As reported for the two other bacteriocins of p9B4-6 (35), no antagonistic activity of lactococcin B in cells or lysates of E. coli(pMB580) could be observed. In an attempt to express lactococcin B in E. coli, the bacteriocin operon of pMB580 was introduced into the E. coli expression vector pT712. The 0.97-kb HindII-EcoRI fragment of pMB580 (the Scal site was lost as a consequence of the cloning, and therefore, the EcoRI site of the multiple cloning site was used) was cloned between the Hindll and EcoRI sites of pT712. As the HindII site is located between the -35 and -10 regions (Fig. 2) , this disrupted the promoter of the bacteriocin operon. In the resulting plasmid, pT580, the bacteriocin operon was placed under control of the T7 RNA polymerase-specific promoter. After induction of the T7 RNA polymerase gene, samples of E. coli BL21(DE3) carrying pT580 were subjected to tricine-SDS-PAGE and subsequently examined for bacteriocin activity. At a position corresponding to about 6.5 kDa, a zone of inhibition of growth that was absent in samples of E. coli BL21(DE3) containing pT712 was observed (Fig. 5) . The zone of inhibition produced by a sample of the supernatant of a culture of IL1403(pMB580) was found at a position corresponding to about 3.4 kDa (Fig. 5) . Apparently, the size of the lactococcin B molecule secreted by the L. lactis cells is less than that of the polypeptide responsible for the antagonistic activity in the E. coli extracts. No bacteriocin activity in the supernatant of the E. coli culture containing pT580 could be detected. An extract of E. coli BL21(DE3) containing pMB580 did not give rise to antagonistic activity on the gel (Fig. 5, lane 4) . Holo et al. (12) have shown that the bacteriocin encoded by lcnA is synthesized as a precursor of 75 amino acids and is processed by removal of the N-terminal 21 amino acids. As shown in Fig. 4 5' part of lcnB to obtain the mature-sized bacteriocin as the nt of lactococcin primary translation product did not result in activity in cells from that of the or lysates of L. lactis and E. coli. Either the truncated gene is poorly expressed or the N-terminal part is essential to get an active product. The molecular size of the primary translation product specified by lcnB is 7.6 kDa. After deletion of its 21 N-terminal amino acids, postulated on the basis of the similarity to lactococcin A, the mature product would be 5.3 kDa. The discrepancy between these values and the molecular sizes determined by tricine-SDS-PAGE is probably due to the hydrophobic nature of the polypeptide specified by IcnB. Muriana and Klaenhammer (23) observed a similar difference between the molecular size deduced from SDS-PAGE and that determined from the amino acid composition of the purified bacteriocin lactacin F.
Recently, the bacteriocin pediococcin PA-1 from Pediococcus acidilactici PAC 1.0 was purified and its amino acid sequence was determined (11, 21) . Subsequently, the bacte-. tricine.SDSpoly riocin structural gene was cloned and sequenced, and it was triclne-SDS-poly-shown that the bacteriocin molecule was synthesized as a (24) . Also in this case, cleavage occurred at the C-terminal side of two glycine residues, resulting in the formation of a mature peptide of 57 amino acids (24) . As is shown in Fig. 3 , a similar cleavage site behind two glycine residues was also found in the precursor of lactococcin A, and on the basis of similarity between their N termini, most probably this also applies to the lactococcin B and M precursors. Thus, it would seem that a common cleavage site is used in lactic acid bacteria and that a similar processing mechanism underlies maturation of a variety of small hydrophobic bacteriocins in these organisms.
